NorthCrest Asset Manangement’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
BCAM
CIM
HCA
AAM
FG
DAS
FFA
GI
TWD
NorthCrest Asset Manangement's RDY Position: Q3 2026 in Review
NorthCrest Asset Manangement held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2026 at 35,100 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #701.
NorthCrest Asset Manangement first reported a position in RDY in Q4 2021 and has held it in 20 quarters since. The position peaked at $881K in Q3 2024. 13 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- NorthCrest Asset Manangement held 35,100 shares of Dr. Reddy's Laboratories worth $428K as of Q3 2026.
- NorthCrest Asset Manangement left its Dr. Reddy's Laboratories share count unchanged in Q3 2026.
- Dr. Reddy's Laboratories made up 0.01% of NorthCrest Asset Manangement's portfolio in Q3 2026, its #701 holding.
- NorthCrest Asset Manangement first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 20 quarters since.
- NorthCrest Asset Manangement's Dr. Reddy's Laboratories position peaked at $881K in Q3 2024.
- 13 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.